Interim data from NHLBI examining 3 international trials suggesting decreased morbidity and mortality for COVID-19 patients with therapeutic anticoagulation for patients not in the ICU. Please share this important summary. IT CAN SAVE LIVES.
VIEW ARTICLE
VIEW ARTICLE
![ATTACC, REMAP-CAP, and ACTIV-4 Logos ATTACC, REMAP-CAP, and ACTIV-4 Logos](https://www.venousforum.org/wp-content/uploads/2021/12/mpRCT-image-554x1024-1.jpg)